Hepatocellular Carcinoma

Information, Symptoms, Treatments and Resources

Blank
Previous | Next
Definition

Hepatocellular carcinoma is cancer of the liver.

Alternative Names

Primary liver cell carcinoma; Tumor - liver; Liver cancer; Cancer - liver

Causes, incidence, and risk factors

Hepatocellular carcinoma accounts for 80 - 90% of all liver cancers. This type of cancer occurs more often in men than women, usually in people 50 to 60 years old. The disease is more common in parts of Africa and Asia than in North or South America and Europe.

The cause of liver cancer is usually cirrhosis (scarring of the liver). Cirrhosis may be caused by viral hepatitis, primarily hepatitis B and C, alcohol abuse, hemochromatosis, certain autoimmune diseases of the liver, and other diseases that result in chronic inflammation of the liver. The most common cause for cirrhosis in the United States is alcohol abuse.

Symptoms

  • Abdominal pain or tenderness, particularly in the right-upper quadrant
  • Enlarged abdomen
  • Easy bruising or bleeding
  • Jaundice (a yellow discoloration of the skin and eyes)

Signs and tests

Treatment

Aggressive surgery or liver transplantation may be successful in treating small or slow-growing tumors if they are diagnosed early.

Chemotherapy and radiation treatments are not usually effective but may be used to shrink large tumors so that surgery has a greater chance of success.

Expectations (prognosis)

The usual outcome is poor, because only 10 - 20% of hepatocellular carcinomas can be removed completely using surgery. If the cancer cannot be completely removed, the disease is usually deadly within 3 to 6 months, although this varies greatly. Survival much longer than this occasionally occurs.

Complications

Calling your health care provider

Call your health care provider if persistent abdominal pain develops, particularly if there has been a history of any liver disease.

Prevention

Preventing and treating viral hepatitis may help reduce risk. Avoid excessive alcohol consumption. Certain patients may benefit from hemochromatosis screening.

Previous | Next
Review date: September 11, 2006
Reviewed by: Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. � 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

MedHelp Health Answers
Submit